Table 1.
Demographic data
| Demographic | Safety population (n = 151) | Efficacy (ITT) population (n = 80) |
| Gender, n (%) | ||
| Male | 66 (44) | 36 (45) |
| Female | 85 (56) | 44 (55) |
| Mean (SD) age in years | 57.1 (12.2) | 56.8 (13.0) |
| Age in years, n (%) | ||
| <65 | 104 (69) | 55 (69) |
| ≥65 | 47 (31) | 25 (31) |
| Race, n (%) | ||
| White | 131 (86.8) | 72 (90.0) |
| Black | 12 (7.9) | 6 (7.5) |
| Asian | 1 (0.7) | 0 |
| Other | 7 (4.6) | 2 (2.5) |
| Mean (SD) height, cm | 168.7 (9.8) | 169.2 (9.3) |
| Mean (SD) weight, kg | 73.0 (19.1) | 74.5 (17.8) |
| Mean (SD) duration since diagnosis in years | 3.2 (4.5) | 3.7 (5.2) |
| Median (range) duration since diagnosis in years | 1.6 (0.0–30.3) | 2.17 (0.0–30.3) |
| Cancer treatment in previous 6 months, n (%) | ||
| Chemotherapy | 84 (56) | 43 (54) |
| Radiation | 38 (25) | 15 (19) |
ITT, intent-to-treat; SD, standard deviation.